Erasca, Inc. (ERAS)
Nasdaq: ERAS · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 12, 2026 | Mar 20, 2025 | Mar 27, 2024 | Mar 23, 2023 | Mar 24, 2022 | · |
| Research and development | 92,854 | 115,359 | 103,821 | 112,457 | 73,922 | 29,550 |
| General and administrative | 38,551 | 41,728 | 37,704 | 32,993 | 22,616 | 7,957 |
| Total operating expenses | 140,905 | 179,587 | 141,525 | 247,450 | 124,883 | 109,252 |
| Operating income | -140,905 | -179,587 | -141,525 | -247,450 | -124,883 | -109,252 |
| Interest income (expense), net | 16,607 | 20,093 | 16,712 | 4,902 | 190 | 336 |
| Other income (expense), net | · | · | · | -257 | 314 | -102 |
| Total non-operating income (expense) | 16,359 | 17,937 | 16,483 | 4,645 | 2,119 | 7,592 |
| Income before income taxes | -124,546 | -161,650 | · | · | · | · |
| Income tax expense | 0 | 0 | · | · | · | · |
| Net income including non-controlling interests | -124,546 | -161,650 | -125,042 | -242,805 | -122,764 | -101,660 |
| Net income | -124,546 | -161,650 | -125,042 | -242,805 | -122,764 | -101,660 |
| Earnings per share, basic | -0.44 | -0.69 | -0.83 | -1.99 | -1.85 | · |
| Earnings per share, diluted | -0.44 | -0.69 | -0.83 | -1.99 | -1.85 | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.85 | -4.83 |
| Weighted average shares, basic | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · |
| Weighted average shares, diluted | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 66,290,592 | 21,037,540 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted